ITOC2 – 008. Melanoma differentiation-associated protein 5 (MDA5)-based tumour immunotherapy reprograms M2/G2-polarised myeloid-derived suppressor cells (MDSCs)

European Journal of Cancer ◽

10.1016/j.ejca.2015.01.021 ◽

2015 ◽

Vol 51 ◽

pp. S3

Author(s):

Kirchleitner V. Sabrina ◽

Schrom Eva ◽

Endres Stefan ◽

Düwell Peter ◽

Schnurr Max

Keyword(s):

Suppressor Cells ◽

Myeloid Derived Suppressor Cells ◽

Tumour Immunotherapy

Download Full-text

Decision letter for "Human monocytic myeloid‐derived suppressor cells impair B‐cell phenotype and function in vitro"

10.1002/eji.201948240/v2/decision1 ◽

2019 ◽

Keyword(s):

B Cell ◽

Suppressor Cells ◽

Cell Phenotype ◽

Myeloid Derived Suppressor Cells ◽

And Function

Download Full-text

Review for "Human monocytic myeloid‐derived suppressor cells impair B‐cell phenotype and function in vitro"

10.1002/eji.201948240/v1/review1 ◽

2019 ◽

Keyword(s):

B Cell ◽

Suppressor Cells ◽

Cell Phenotype ◽

Myeloid Derived Suppressor Cells ◽

And Function

Download Full-text

Review for "Elevated monocytic‐myeloid derived suppressor cells positively correlate with infection frequency in children with RRTIs"

10.1002/eji.202048629/v2/review1 ◽

2020 ◽

Keyword(s):

Suppressor Cells ◽

Infection Frequency ◽

Myeloid Derived Suppressor Cells

Download Full-text

Review for "Elevated monocytic‐myeloid derived suppressor cells positively correlate with infection frequency in children with RRTIs"

10.1002/eji.202048629/v1/review1 ◽

2020 ◽

Keyword(s):

Suppressor Cells ◽

Infection Frequency ◽

Myeloid Derived Suppressor Cells

Download Full-text

Decision letter for "Human splenic polymorphonuclear myeloid‐derived suppressor cells (PMN‐MDSC) are strategically‐located immune regulatory cells in cancer"

10.1002/eji.202048666/v2/decision1 ◽

2020 ◽

Keyword(s):

Suppressor Cells ◽

Myeloid Derived Suppressor Cells ◽

Regulatory Cells

Download Full-text

Decision letter for "Human splenic polymorphonuclear myeloid‐derived suppressor cells (PMN‐MDSC) are strategically‐located immune regulatory cells in cancer"

10.1002/eji.202048666/v1/decision1 ◽

2020 ◽

Keyword(s):

Suppressor Cells ◽

Myeloid Derived Suppressor Cells ◽

Regulatory Cells

Download Full-text

Review for "Impaired antigen-specific lymphocyte priming in mice after Toll-like receptor 4 activation via induction of monocytic myeloid-derived suppressor cells"

10.1002/eji.201847805/v2/review2 ◽

2018 ◽

Keyword(s):

Suppressor Cells ◽

Myeloid Derived Suppressor Cells ◽

Toll Like Receptor ◽

Toll Like Receptor 4

Download Full-text

Clinical Impact of Myeloid-Derived Suppressor Cells, Lymphocyte Subsets, and Neutrophil-to-Lymphocyte Ratio in Patients with Colorectal Cancer

Laboratory Medicine Online ◽

10.3343/lmo.2020.10.1.75 ◽

2020 ◽

Vol 10 (1) ◽

pp. 75

Author(s):

Min-Gu Kang ◽

Chang Hyun Kim ◽

Soo Hyun Kim ◽

Jong-Hee Shin ◽

Hye Ran Kim ◽

...

Keyword(s):

Colorectal Cancer ◽

Lymphocyte Subsets ◽

Suppressor Cells ◽

Clinical Impact ◽

Neutrophil To Lymphocyte Ratio ◽

Myeloid Derived Suppressor Cells ◽

Lymphocyte Ratio

Download Full-text

Myeloid-derived suppressor cells (MDSC) mediate the positive feedback loop of prostate tumor-bone interactions

Bone Abstracts ◽

10.1530/boneabs.5.p112 ◽

2016 ◽

Author(s):

Serk in Park

Keyword(s):

Positive Feedback ◽

Feedback Loop ◽

Suppressor Cells ◽

Prostate Tumor ◽

Myeloid Derived Suppressor Cells ◽

Positive Feedback Loop

Download Full-text

VEGF in ovarian cancer suppresses T cell activity by eliciting Myeloid Derived Suppressor Cells (MDSC) into tumor microenvironment

10.26226/morressier.5770e29cd462b80290b4bf91 ◽

2016 ◽

Author(s):

Naoki Horikawa

Keyword(s):

Ovarian Cancer ◽

T Cell ◽

Tumor Microenvironment ◽

Cell Activity ◽

Suppressor Cells ◽

Myeloid Derived Suppressor Cells

Download Full-text